Impact Factor
2.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.58
107 total citations
h5-index
15
h5 depth signal
Cited share
47.8%
33 of 69
Total citations
107
Citation footprint
Metric signal
1.55
External metric anchor
Self-citation
2.8%
3 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
165
China
81
Turkey
56
United States
41
South Korea
31
Citing Fields of Research
Urology
430
Prostate Cancer
61
Kidney Diseases
55
Physiology
12
Anesthetic & Pain Medicine
11
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
805
Articles tracked across the journal lifetime
Indexed publication set
69
33 cited publications
Last 12 months
69
5.8 publications/month
Open access share
31.9%
22 OA publications in the last year
Leading citing country
Japan
165 citing publications
Leading citing field
Urology
430 citing publications
Latest tracked publication
9 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan. 2015-
v7n1, Jan. 2015- ; Selected citations only before this date
Research Focus & Classification
Indexed Subjects
Urology
Issuing & Sponsoring Bodies
Contributor
Nihon Hainyō Kinō Gakkai
Contributor
Taehan Paenyo Chang'ae Yosilgŭm Hakhoe
Contributor
Taiwan niao shi jin fang zhi xie hui
Broad Categories
Pathology
Urology
MeSH Descriptors
Urinary Tract Physiological Phenomena
Urologic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/luts.70100
Open DOI
Changes in Bladder Outlet Obstruction After Photoselective Vaporization of the Prostate in Men With and Without Detrusor Underactivity: A Retrospective Propensity Score‐Matched Study
Objectives: To compare symptomatic improvement after photoselective vaporization of the prostate (PVP) between patients with and without detrusor underactivity (DU), together with objective changes in urodynamic parameters assessed by pr...
02
DOI 10.1111/luts.70099
Open DOI
Sex Differences in Prescribing Patterns of Anticholinergics and β3‐Adrenoceptor Agonists for Overactive Bladder: A Nationwide Study in Japan, FY2017 – FY2024
Objectives: Drug treatment for overactive bladder (OAB) is changing, with an increasing share of β3‐adrenoceptor agonists relative to anticholinergics, but it is not known how far this change has progressed in older people, who are most ...
03
DOI 10.1111/luts.70068
Open DOI
Issue Information
04
DOI 10.1111/luts.70097
Open DOI
LiESWT on Non‐Neurogenic LUTS : An Updated Systematic Review and Meta‐Analysis
Objectives: To evaluate the efficacy of low‐intensity extracorporeal shockwave therapy (LiESWT) for non‐neurogenic lower urinary tract symptoms (LUTS). Materials and Methods: A systematic review and meta‐analysis was conducted according ...
05
DOI 10.1111/luts.70096
Open DOI
Impact of Photoselective Vaporization of the Prostate on Renal Function: A Pressure Flow Study‐Based Analysis
Objectives: This study assessed changes in renal function from baseline to 6 months after photoselective vaporization of the prostate (PVP). Methods: Among 117 consecutive patients who underwent PVP at our institution between November 20...
06
DOI 10.1111/luts.70098
Open DOI
Symptom Bother Is Associated With Medical Care‐Seeking for LUTS in Japanese Women: A Survey of 1800 Women
Background and Objective: Lower urinary tract symptoms (LUTS) are highly prevalent in women, yet care‐seeking is very low, and a large treatment gap remains despite the availability of effective treatments. Previous studies, mainly from ...
07
DOI 10.1111/luts.70095
Open DOI
Efficacy of Vibegron in Overactive Bladder: A Bayesian Cross‐Trial Synthesis of Benefit Probabilities and Decision Thresholds
Objectives: To synthesize published placebo‐controlled trials of vibegron monotherapy for overactive bladder (OAB) and quantify posterior probabilities of benefit and decision‐threshold exceedance. Methods: We extracted published placebo...
08
DOI 10.1111/luts.70094
Open DOI
Safety and Efficacy of Rezūm Water Vapor Energy Therapy for Benign Prostatic Hyperplasia With Continued Antithrombotic Therapy: A Comparative Study
Objectives: Evidence regarding the safety of water vapor energy (WAVE) therapy in patients continuing antithrombotic (AT) agents remains limited. This study compared the safety and efficacy of WAVE therapy between patients receiving AT t...
09
DOI 10.1111/luts.70092
Open DOI
Sex‐ and Age‐Specific Trends in Prescriptions of Beta‐3 Agonists and Anticholinergics in Japan: A Nationwide Prescription Database Study
Introduction: To investigate the nationwide trends in pharmacological treatment for overactive bladder among Japanese adults, specifically focusing on the β3‐agonists to anticholinergics prescribed tablet ratio (BAPR) and how this ratio ...
10
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 1, issue 1 (June 2009).
Print issues ceased with v. 12 (2020).
Also issued online.
Access to this journal is available free online within institutions in the developing world through the HINARI initiative with the WHO.
An official journal of the Japanese Neurogenic Bladder Society, the Korean Continence Society, and the Taiwanese Continence Society.